Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Busam

Showing results (21-30 of 93) with videos related to

Pageof 10
Sort By:
Annals of Surgical Oncology|August 9, 2002
Multivariate prognostic model for patients with thick cutaneous melanoma: importance of sentinel lymph node statusCristina R Ferrone, Katherine S Panageas, Klaus Busam, et al.
Annals of Surgical Oncology|December 31, 2003
Primary vaginal melanoma: a critical analysis of therapyThomas J Miner, Ruby Delgado, Jonathan Zeisler, et al.
Cell|November 13, 2012
Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesisNora Pencheva, Hien Tran, Colin Buss, et al.
The American Journal of Surgical Pathology|February 28, 2012
A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expressionThomas Wiesner, Rajmohan Murali, Isabella Fried, et al.
The Journal of Molecular Diagnostics : JMD|June 27, 2013
A genome-wide high-resolution array-CGH analysis of cutaneous melanoma and comparison of array-CGH to FISH in diagnostic evaluationLu Wang, Mamta Rao, Yuqiang Fang, et al.
Journal of Translational Medicine|December 23, 2004
Clinical significance of BRAF mutations in metastatic melanomaDavid Z Chang, Katherine S Panageas, Iman Osman, et al.
The Journal of Dermatological Treatment|September 25, 2018
Treatment of Rosai-Dorfman disease with oral bexarotene: a case seriesShamir Geller, Klaus Busam, Paul A Hamlin, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|May 16, 2013
Cost-effectiveness of a FISH assay for the diagnosis of melanoma in the USAAnuraag R Kansal, Alissa J Shaul, Sean Stern, et al.
The Journal of Investigative Dermatology|February 17, 2012
Investigation of the effect of MDM2 SNP309 and TP53 Arg72Pro polymorphisms on the age of onset of cutaneous melanomaJavier Cotignola, Joanne F Chou, Pampa Roy, et al.
Diseases of the Colon and Rectum|June 7, 2003
Long-term outcome of perianal Paget's diseaseMartin D McCarter, Stuart H Q Quan, Klaus Busam, et al.
Pageof 10

Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
Annals of Surgical Oncology|August 9, 2002
Multivariate prognostic model for patients with thick cutaneous melanoma: importance of sentinel lymph node statusCristina R Ferrone, Katherine S Panageas, Klaus Busam, et al.
Annals of Surgical Oncology|December 31, 2003
Primary vaginal melanoma: a critical analysis of therapyThomas J Miner, Ruby Delgado, Jonathan Zeisler, et al.
Cell|November 13, 2012
Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesisNora Pencheva, Hien Tran, Colin Buss, et al.
The American Journal of Surgical Pathology|February 28, 2012
A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expressionThomas Wiesner, Rajmohan Murali, Isabella Fried, et al.
The Journal of Molecular Diagnostics : JMD|June 27, 2013
A genome-wide high-resolution array-CGH analysis of cutaneous melanoma and comparison of array-CGH to FISH in diagnostic evaluationLu Wang, Mamta Rao, Yuqiang Fang, et al.
Journal of Translational Medicine|December 23, 2004
Clinical significance of BRAF mutations in metastatic melanomaDavid Z Chang, Katherine S Panageas, Iman Osman, et al.
The Journal of Dermatological Treatment|September 25, 2018
Treatment of Rosai-Dorfman disease with oral bexarotene: a case seriesShamir Geller, Klaus Busam, Paul A Hamlin, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|May 16, 2013
Cost-effectiveness of a FISH assay for the diagnosis of melanoma in the USAAnuraag R Kansal, Alissa J Shaul, Sean Stern, et al.
The Journal of Investigative Dermatology|February 17, 2012
Investigation of the effect of MDM2 SNP309 and TP53 Arg72Pro polymorphisms on the age of onset of cutaneous melanomaJavier Cotignola, Joanne F Chou, Pampa Roy, et al.
Diseases of the Colon and Rectum|June 7, 2003
Long-term outcome of perianal Paget's diseaseMartin D McCarter, Stuart H Q Quan, Klaus Busam, et al.
Pageof 10